Targeting Inflammation With Nanosized Drug Delivery Platforms in Cardiovascular Diseases: Immune Cell Modulation in Atherosclerosis

Atherosclerosis (AS) is a disorder of large and medium-sized arteries; it consists in the formation of lipid-rich plaques in the intima and inner media, whose pathophysiology is mostly driven by inflammation. Currently available interventions and therapies for treating atherosclerosis are not always...

Descripción completa

Detalles Bibliográficos
Autores principales: Cervadoro, Antonio, Palomba, Roberto, Vergaro, Giuseppe, Cecchi, Roberta, Menichetti, Luca, Decuzzi, Paolo, Emdin, Michele, Luin, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277804/
https://www.ncbi.nlm.nih.gov/pubmed/30542650
http://dx.doi.org/10.3389/fbioe.2018.00177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277804/
https://www.ncbi.nlm.nih.gov/pubmed/30542650
http://dx.doi.org/10.3389/fbioe.2018.00177

Ejemplares similares